WellTheory

WellTheory is a chronic care management platform that offers personalized solutions for managing and addressing the root causes of autoimmune and inflammatory disorders. With its virtual platform, the company provides a holistic approach that includes a dedicated care team, personalized treatment plans, education resources, and expert-led programs. Its services also include one-on-one coaching on emotional and mental well-being, stress management, sleep hygiene, and nutrition. WellTheory works closely with its members, setting goals, providing ongoing health education, offering continuous support through chat and live coaching sessions, and enabling symptom tracking.

Unlike traditional healthcare providers that often focus on treating symptoms, WellTheory's platform focuses on identifying and addressing the root causes of autoimmune conditions. The company claims that since its launch in November 2022, its D2C solution has recorded an 85% reduction in fatigue, a 53% decrease in pain, and a 74% increase in overall life satisfaction within 20 weeks. Additionally, it also claims to have led to healthcare cost savings, with an 85% decrease in ER and urgent care visits within 16 weeks and estimated annual savings of over USD 11,000 per member on biologics. Further, the company supports 100+ conditions, including rheumatoid arthritis, Crohn's disease, and vitiligo.

WellTheory operates a D2C business model, with membership priced at USD 125 per month per member and a B2B2C business model (launched in October 2023 ), offering an enterprise solution for employers and payers.

Key customers and partnerships

In January 2024, the company partnered with Maven Clinic, to provide Maven Clinic’s employees with free access to WellTheory's platform.

Funding and financials

The firm launched from stealth and raised USD 7.2 million in a seed funding round led by Accel in November 2022. The company had not disclosed how the new funds were to be used.